Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 2833 for “"SARS-CoV"”.
-
Evaluating Immunity to SARS-CoV-2 and Risk of Breakthrough SARS-CoV-2 Infection
Understanding who is at risk of SARS-CoV-2 infection is an important challenge in infectious disease epidemiology. As the COVID-19 pandemic progressed and individuals aquired immunity through infection, vaccination, and the combination of these two, the determinants of individual infection risk …
-
SARS-CoV-2 detection in wastewater
Submission published under a 24 month embargo labeled 'U of I Access', the embargo will last until 2023-12-01
-
SARS-CoV-2 genų raiškos įvertinimas teigiamuose COVID-19 mėginiuose taikant tris skirtingas SARS-CoV-2 detekcijos sistemas /
… pandemic caused by the rapidly spreading SARS-CoV-2 virus. Therefore, accurate diagnosis of symptomatic and asymptomatic SARS-CoV-2 carriers has been identified as a key aspect to control the spread of COVID-19. Real-time reverse transcription polymerase chain reaction (RT-PCR) is the most …
-
Ανοσία έναντι Sars-CoV 2 μετά από φυσική νόσηση και ορολογικές μέθοδοι διάγνωσης λοίμωξης από Sars-CoV 2
… αναπνευστικού συνδρόμου που προκαλείται από τον SARS-CoV-2 κατά τα οποία έγινε πληθώρα ερευνών για την κατανόηση της αιτιολογίας της πανδημίας, των ανοσολογικών αποκρίσεων και της έγκυρης και έγκαιρης διάγνωσης της νόσου. Τα περισσότερα άτομα που έχουν νοσήσει επιτυγχάνουν κάποιας μορφής ανοσία …
-
Differential Electrostatic Interaction Patterns in SARS-CoV-1 and SARS-CoV-2 variants: A Molecular Dynamics Simulation Study
The SARS-related coronavirus (SARS-rCoV) is a highly contagious virus that has raised significant worldwide health concerns. It caused outbreaks in 2002-2003 and more recently in 2019-2020 with SARS-CoV-2. SARS-CoV-2 is responsible for the COVID-19 pandemic, which has resulted in a significant …
-
Evaluation of two SARS-CoV-2 immunoassays
… (qualitative) and anti-spike (quantitative) SARS-CoV-2 immunoassays to determine whether the performance of the assays is acceptable for diagnostic use in the Groote Schuur Hospital virology/chemistry laboratory, as well as other National Health Laboratory Service (NHLS) laboratories in South …
-
Cardiovascular SARS-CoV-2 Tropism and Immunopathology
Coronavirus Disease 2019 (COVID-19) is caused by SARS-CoV-2, a member of beta-coronaviridae family. This single-stranded RNA virus is transmitted through a respiratory route, binds to a host receptor ACE2 and enters lung pneumocytes, causing fulminant pulmonary disease in a subset of patients. In …
-
Infection at mucosal surfaces: SARS-CoV-2
<p>The pandemic caused by the SARS-CoV-2 virus has had a profound international impact, causing widespread morbidity and mortality as well as substantial indirect secondary consequences of the restrictions implemented to constrain the virus. During 2020 the University of Oxford developed a …
-
High Throughput Sequencing of SARS-CoV-2
… in Wuhan China, later to be classified as SARS-CoV-2 and commonly referred to as COVID-19. This outbreak eventually spread to a global pandemic that has affected over 132 million people worldwide. Our goal was to develop optimized methods to sequence the whole SARS-CoV-2 genome so we could …
-
Μελέτη διασποράς μεταλλαγμένων στελεχών SARS-CoV-2
… ολόκληρη η υφήλιος μαστίζεται από την πανδημία COVID-19 που προκαλείται από τον SARS-CoV-2, ένα νέο μέλους της οικογένειας των κορωνοϊών που πρωτοεμφανίστηκε τον Δεκέμβριο του 2019 στην Κίνα. Ο νέος ιός, χάρη και στην ευκολία των μετακινήσεων που έχει καταστήσει εφικτή η σύγχρονη τεχνολογία, …
-
Επιδημιολογία στελεχών SARS CoV-2 στην κοινότητα
ΠΕΡΙΛΗΨΗ Η επιδημία από τον ιό SARS CoV-2 ξεκίνησε το Δεκέμβριο του 2019 στην πόλη Wuhan της Κίνας και λόγω της ραγδαίας παγκόσμιας εξάπλωσης κηρύχθηκε πανδημία από τον Παγκόσμιο Οργανισμό Υγείας στις 11 Μαρτίου του 2020. Έως τις αρχές Ιουλίου του 2021 έχουν αναφερθεί παγκοσμίως περισσότερες από …
-
Pushing the Limits of SARS-CoV-2 Survival: How SARS-CoV-2 Responds to Quaternary Ammonium Compounds and Wastewater
SARS-CoV-2 is the virus responsible for the current global pandemic, COVID-19. Because this virus is novel, little is known about its sensitivity to disinfection. In this study, we performed suspension tests against SARS-CoV-2 using three commercially available quaternary ammonium compound (Quat) …
-
RNA STRUCTURAL-DYNAMICAL HIERARCHY: SARS-COV, SARS-COV-2, AND DELTA/OMICRON VARIANT S2M MONOMERS, KISSING COMPLEXES, AND EXTENDED DUPLEXES
… genomes of severe acute respiratory syndrome (SARS), SARS-coronavirus-2 (SARS-CoV-2), and the Delta and Omicron variants responsible for the COVID-19 pandemic, is a potential antiviral target due to its high sequence conservation across several viral families. Despite the efforts of the …
-
MODELLING THE TRANSMISSION DYNAMICS OF SARS-CoV-2
… thesis, taking the coronavirus disease 2019 (COVID-19) as the disease of interest, we developed hierarchical models to characterize the transmission patterns and estimate impacts of various non-pharmaceutical interventions on institutional, national and international outbreaks. For estimation …
-
Investigating transcriptomic markers of SARS-CoV-2 response
… 700 million Severe Acute Respiratory Syndrome 2 (SARS-CoV-2) infections worldwide, understanding the host immune response upon infection is crucial in informing about and preventing a severe disease course, in this case Coronavirus-19 (COVID-19). Majority of studies undertaken thus far utilise …
-
Blutgefäßmodelle zur Untersuchung von SARS-CoV-2-Infektionen
Da SARS-CoV-2-Infektionen kardiovaskuläre Symptome und einen Zytokinsturm bei Patienten auslösen können, stellt sich die Frage, ob das Endothel der Blutgefäße direkt empfänglich für eine Infektion ist. Ziel dieser Arbeit war es Blutgefäßmodelle hierfür zu etablieren. Dazu wurden …
-
SARS-CoV-2 viruso helikazės nsp13 mechanistiniai tyrimai /
In the face of still ongoing COVID-19 diagnoses and mortality rates around the world, the development of drugs capable of targeting all SARS-CoV-2 strains is crucial, given the constant mutations and potential emergence of more dangerous virus variants. To address this, identifying a conserved …
-
NEW-ONSET HYPERGLYCEMIA AFTER SARS-COV-2 INFECTION
… were hospitalized for coronavirus disease 2019 (COVID-19) have a higher prevalence of hyperglycemia. By altering glucose homeostasis, cytokine release brought on by The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection may hasten the onset of metabolic changes. Here, they are …
-
Characterization of the SARS-CoV-2 Nsp13 Helicase
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent responsible for the coronavirus disease of 2019 (COVID-19) pandemic, which has infected millions of people worldwide. To date, several vaccines and antivirals have been developed against SARS-CoV-2; however, its …
Page 1 of 142